Thiago Carvalho on Nostr: 'At this first prespecified interim analysis, adjuvant pembrolizumab, as compared ...
'At this first prespecified interim analysis, adjuvant pembrolizumab, as compared with observation, was associated with a significant lengthening of disease-free survival in patients with high-risk muscle-invasive urothelial carcinoma after radical surgery.'
#Immunology #Immunotherapy
https://www.nejm.org/doi/full/10.1056/NEJMoa2401726Published at
2024-09-15 08:08:31Event JSON
{
"id": "888fa425625679b28ca61e475794278d369d366b0ee01ea7c09c23f3737a913a",
"pubkey": "376d961fc946cb96839a4d257809dc9e6d237e2d0cc158199b8cc5c5771939a6",
"created_at": 1726387711,
"kind": 1,
"tags": [
[
"t",
"immunology"
],
[
"t",
"immunotherapy"
],
[
"proxy",
"https://qoto.org/users/cyrilpedia/statuses/113140545081003174",
"activitypub"
]
],
"content": "'At this first prespecified interim analysis, adjuvant pembrolizumab, as compared with observation, was associated with a significant lengthening of disease-free survival in patients with high-risk muscle-invasive urothelial carcinoma after radical surgery.'\n#Immunology #Immunotherapy \nhttps://www.nejm.org/doi/full/10.1056/NEJMoa2401726",
"sig": "ca8a27e535ff99fb333d59515342d84982480ddf2042c8f493e60a56ede8c36dec03178621854965b1dbc53d4de22237f3c6f91c36747418fdcc09b626db07ee"
}
